Bloomberg Intelligence cover image

Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal

Bloomberg Intelligence

00:00

Merck's $6.7B Acquisition of Terns

Michelle Davis and hosts explain Merck's $53/share bid for Terns to bolster its leukemia pipeline.

Play episode from 02:12
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app